文献速递主动脉疾病

高危患者腹主动脉瘤选择性筛查的趋势、危险因素与结局

Trends, risk factors, and outcomes of selective screening for abdominal aortic aneurysms in at-risk patients.
PubMed 文献 · J Vasc Surg · 2024-12-17

该研究查询TriNetX数据库2007至2023年65至75岁有常规初级保健就诊者,分析男性吸烟者、男性不吸烟者和女性吸烟者的腹主动脉瘤筛查趋势、影响因素及筛查与未筛查者的结局。结果显示各组筛查率均低但2023年达峰,男性吸烟者最高为21.2%,筛查与未破裂腹主动脉瘤诊断及腹主动脉瘤腔内修复相关。

要点

  • 男性吸烟者筛查患病率最高为21.2%,男性不吸烟者为3.1%,女性吸烟者为0.90%。
  • 高脂血症和他汀使用与所有组筛查相关(P < .05),个人冠心病史与未筛查相关。
  • 所有组中筛查与未破裂腹主动脉瘤诊断及腹主动脉瘤腔内修复相关(P < .05)。

核心结论

  • 所有高危人群的腹主动脉瘤筛查均增加腹主动脉瘤的诊断和治疗,但所有组的筛查率均低,即使CT/MRI使用增加。
  • 具有腹主动脉瘤强危险因素的患者未接受筛查。
  • 需要与初级保健提供者合作以提高筛查率并确保具有最具临床意义危险因素的患者得到适当管理。

研究设计与样本

  • 查询TriNetX人群数据库,纳入2007至2023年间65至75岁有常规初级保健就诊的受试者,构建男性吸烟者、男性不吸烟者和女性吸烟者队列。
  • 计算超声和计算机断层扫描/磁共振成像(CT/MRI)筛查腹主动脉瘤的患病率及1年和3年发病率。
  • 比较筛查与未筛查患者的人口学特征、诊断和药物,并比较未匹配的筛查与未筛查患者腹主动脉瘤诊断和修复率。

主要发现

  • 所有组筛查在2023年达峰,男性吸烟者筛查患病率最高为21.2%,其次男性不吸烟者为3.1%,女性吸烟者为0.90%。
  • 男性吸烟者1年筛查发病率增加,2021年达峰值8.2%;男性不吸烟者1年发病率2020年平台期为1.9%;女性吸烟者整个观察期在0.25%至0.35%之间。
  • 至2023年,男性吸烟者、男性不吸烟者和女性吸烟者分别有23.6%、14.3%和24.3%通过CT/MRI筛查,CT/MRI占所有三个队列筛查事件的大多数。
  • 高脂血症和他汀使用与所有组筛查相关(P < .05),个人冠心病史与未筛查相关;男性不吸烟者筛查与高血压、糖尿病和慢性阻塞性肺疾病相关(P < .05);女性吸烟者筛查与冠心病家族史相关(比值比1.50;P < .001)。
  • 所有组中筛查与未破裂腹主动脉瘤诊断及腹主动脉瘤腔内修复相关(P < .05);筛查的女性吸烟者腹主动脉瘤诊断率与男性不吸烟者相似(分别为4.58%和4.37%)。

临床怎么用

  • 原文结论指出需要与初级保健提供者合作以提高筛查率并确保具有最具临床意义危险因素的患者得到适当管理。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: For men ages 65 to 75 years without a smoking history and for women ages 65 to 75 years with a smoking history, the United States Preventative Service Task Force recommends that primary care providers (PCPs) use their clinical judgement when offering abdominal aortic aneurysm (AAA) screening. This study describes the trends in screening for these cohorts, identifies factors that may influence screening rates, and compares outcomes between screened and unscreened patients. METHODS: The TriNetX population database was queried for subjects with routine PCP visit between ages 65 to 75 from 2007 to 2023 to create cohorts of male smokers, male nonsmokers, and female smokers. Prevalence and 1- and 3-year incidences of AAA screening by ultrasound and computed tomography scans/magnetic resonance imaging (CT/MRI) were calculated. Screened and unscreened patients' demographics, diagnoses, and medications were compared. Rates of AAA diagnosis and repair were compared between unmatched screened and unscreened patients. RESULTS: Screening for all groups peaked in 2023. Male smokers had the highest screening prevalence (21.2%), followed by male nonsmokers (3.1%) and female smokers (0.90%). The 1-year incidence of screening increased for male smokers, peaking at 8.2% in 2021. The 1-year incidence plateaued at 1.9% for male nonsmokers in 2020 and remained between 0.25% and 0.35% for female smokers for the whole observation period. By 2023, 23.6%, 14.3%, and 24.3% of male smokers, male nonsmokers, and female smokers had been screened via CT/MRI, respectively, with CT/MRI comprising the majority of screening events for all three cohorts. Hyperlipidemia and statin use were associated with screening for all groups (P < .05), whereas a personal history of coronary artery disease was associated with no screening. Screening for male nonsmokers was associated with hypertension, diabetes, and chronic pulmonary obstructive disease (P < .05). Screening in female smokers was associated with family history of coronary artery disease (odds ratio, 1.50; P < .001). For all groups, screening was associated with unruptured AAA diagnosis and endovascular aortic repair (P < .05). Screened female smokers had similar rates of AAA diagnosis as male nonsmokers (4.58% and 4.37%, respectively). CONCLUSIONS: AAA screening in all at-risk populations increases diagnosis and treatment of AAA, but the screening rate is low for all groups, even with increasing CT/MRI use. Patients with strong risk factors for AAA are not undergoing screening. Collaboration with PCPs is necessary to increase screening rates and ensure that patients with the most clinically consequential risk factors are managed appropriately.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jain P, DiMuzio P, Nooromid M, et al. Trends, risk factors, and outcomes of selective screening for abdominal aortic aneurysms in at-risk patients. J Vasc Surg. 2024. PMID: 39701337. doi:10.1016/j.jvs.2024.12.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。